Nascent BiotechNBIO 
$0.0512.50%24h
12.50%24h
Global rank33520
Market cap$5.34M
Change 7d-10.00%
YTD Performance-75.00%
SP500 benchmarkUnderperform
P/E-2.25
P/S0
Revenue$0
Earnings-$2.80M
Dividend yield-
Main Sector
Healthcare
Nascent Biotech (NBIO) Net Assets
NBIO Net Assets in 2023: $-1.30M
As of 15 Sept 2024, Nascent Biotech net assets is $-1.30M, an increase of 93.03% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Nascent Biotech overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Nascent Biotech Net Assets History from 2019 to 2024
-
Value:-
NBIO Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $-1.30M | 93.03% |
| 2022 | $-671.48K | 42.11% |
| 2021 | $-472.50K | -83.57% |
| 2020 | $-2.88M | -77.54% |
| 2019 | $-12.80M | - |
View the Top Net Assets Companies
